The Nature and Prevalence of Depression in Chronic Schizophrenic In-patients THOMAS A. E. BARNES, DAVID A. CURSON, PETER F. LIDDLEand MEENA PATEL Out of 194 chronic schizophrenicin-patients, depressedmood (item 23 of the PSE)was present in 25 (13%). When compared with 25 matched controls, the patients with depressed mood had significantly higher scores on the MADRS and the Beck Depression Inventory. Serious suicidal ideas and auditory hallucinations were significantly more common in the depressed group. However, there were no significant differences between the matched groups in terms of negative symptoms, Parkinsonism, tardive dyskinesia, anticholinergic medication, or current dose of antipsychotic drug, which suggests that the depression identified was not related to drug treatment, nor was it a direct manifestation or misinterpretation of negative symptoms.
Over three-month follow-up, the MADRS and Beck scores covaried closely with the presence or absence of depressed mood. This depressive syndrome persisted over the three months in the majority of patients originally depressed.
Depressive features in patients with a primary diagnosis of schizophrenia have long been recognised (Mayer-Gross, 1920; Bleuler, 1950) . Between 25%
and 50% of patients may manifest depressive features during the acute phase of schizophrenia (Shanfield et a!, 1970; Donlon et a!, 1976; McGlashan & Carpenter, 1976a,b; Planansky & Johnson, 1978; Mandel et al, 1982) . Studies on the prevalence of depression in established schizophrenia (Falloon et a!, 1978; Knights & Hirsch, 1981; Johnson, 1981; Curson et a!, 1985) all suggest that relapse can be a major factor in the prevalence of depression. For example, in the one-year follow-up by Falloon et a! (1978) , more patients required in patient admission for depression than for psychotic relapse. In two of these studies (Knights & Hirsch, 1981 This idea is supported by the findings of a study by Johnson (1981) , where depression was present in half of a sample of new, acute schizophrenic patients untreated with antipsychotic drugs. proposed. McGlashan & Carpenter (1976b) have used the term â€˜¿ post-psychoticdepression', which implies that the symptoms occur during recovery from a psychotic episode, and constitute patients' response to their recent experience. Other authors have assumed a direct causal role for antipsychotic drugs, especially depot preparations, and have referred to â€˜¿ pharmacogenic depression' (De Alarcon & Carney, 1969; Ananth & Ghadirian, 1980; Galdi, 1983) . Indirectly, drugs may generate Parkinsonian symptoms, such as bradykinesia and loss of spontaneity, that can mimic retarded depression (Rifkin et a!, 1975; Van Putten & May, 1978) . The symptoms of this so-called â€˜¿ akinetic depression' should respond to anticholinergic drugs. However, depression is a relatively common, but often unrecognised, complication of Parkinson's disease (Mayeux et a!, 1981; Jeste et a!, 1984) . The association of depression with the motor disturbance of Parkinsonism may represent shared elements of pathophysiology rather than being due to a misinterpretation of psychomotor retardation. Furthermore, the association between depressive features and certain â€˜¿ negative' schizophrenic symptoms, such as anhedonia, anergia, feelings of emptiness, and emotional withdrawal (Roth, 1970; Stern et a!, 1972; McGlashan & Carpenter, 1976b) remains unclear. Knights & Hirsch (1981) The main aim of the present study was to investigate the nature and prevalence of depression in a population of in-patients with established schizophrenia. The strategy was to identify those patients with depressed mood, as a core feature of depression, and to test whether this symptom is commonly an indication of a depressive syndrome in such patients. By examining the nature of those symptoms commonly associated with depressed mood, we hoped to shed some light on the possible overlap between the clinical assessment of negative symptoms, depression, and drug-induced Parkinsonism in chronic schizophrenic in-patients.
Method
All patients on the 11 non-geriatric long-stay wards of Horton Hospital, Epsom, were screened. Although situated in a semirural area, the catchment area of the hospital has been central London. For the last 20 years it has pursued a vigorous policy of resettlement in the community. The case records of those with a ward diagnosis of schizophrenia were examined, and patients fulfilling DSMâ€"IIIcriteria (American Psychiatric Association, 1980) for schizophrenia were included. Two of the investigators (DAC and MP) rated patients for the presence of item 23, depressed mood, on the PSE, and then completed a full Comprehensive
Psychopathological
Rating Scale (CPRS; Asberg eta!, 1978) using the full scoring range of 1 (absent) to 7 (severe). Patients with PSE ratings 1 (moderate) or 2 (severe) for depressed mood were matched for age, length of illness, and sex, with patients scoring zero. Within one week of assessment the â€˜¿ depressed' patients and their matched controls were blindly assessed by the second two investigators (TREB and PFL) using the following instruments: Scale for Assessment of Negative Symptoms (SANS; Andreasen, 1982) modified to include a specific rating for anhedonia; the Beck Depression Inventory (Beck ci a!, 1961); the Extrapyramidal Rating Scale (EPRS; Simpson & Angus, 1970) ; and rating scales for tardive dyskinesia (Barnes & Trauer, 1982) and akathisia (Barnes & Halstead, 1988) . All the investigators practised joint interviews before the study, and joint ratings were performed throughout the study to check inter-rater agreement. Details of each patient's medication were recorded, and antipsychotic drug dose was converted to chlorpromazine equivalents a day (Davis, 1976; Baldessarini, 1978) .
The matched pairs of initially â€˜¿ depressed' patients and their controls were then reassessed three months later by the same pair of raters, using PSE item 23 and the CPRS. The second two investigators repeated the remainder of the assessment battery and were again blind to the PSE and CPRS results.
Statistics
The data were analysed using the Statistical Package for PSE item 23 and a full CPRS could be completed for 194 patients. The reasons for the failure of the interview in the remaining 28 were: mutism (13); persistent refusal to co-operate (5); poor command of English (4); inability to comprehend questions, including deafness (3); gross thought disorder (2); and absent without leave from the hospital (1).
Prevalence of depressed mood (PSE Item 23)
Of the 194patients rated on PSE item 23, 17patients scored I and 8 scored 2, yielding a point prevalence for depressed mood of 12.9%. The 25 patients with depressed mood and their matched controls were compared on several variables (see Table I ).
At three-month follow-up, 15 patients were still rated as positive for depressed mood, with nine patients scoring 1
on PSE item 23, and six patients scoring 2. However, five of the matched controls had developed depressed mood, four patients scoring 1 and one scoring 2.
Rating scale variables
Montgomery & Asberg (1979) derived a depression rating scale (MADRS) based on ten items of the full CPRS:
sadness; inner tension; inability to feel; pessimisticthoughts; lassitude, concentration difficulties; reduced appetite; reduced sleep; suicidal thoughts; and apparent sadness on observation. The total scores for these ten items in the matched groups at initial assessment and three-month follow-up were compared with the PSE ratings of depressed mood. The Beckdepression score wasalso compared with thePSE depressed mood scores and the MADRS scores. Beck data were missing for six patients (three depressed, three controls) at initialassessmentand, at three-monthfollow-up,for five of the same initial six patients (three depressed, two controls) because of inability or refusal to complete the rating scale.
An orofacial dyskinesia score was derived from the first four items of the tardive dyskinesia rating scale, which rates movement at four sites: periorbital; lips; tongue; and jaw. Akathisia scores were based on the global clinical assessment item of the rating scale. Similarly, the global assessment item of the EPRS was taken as the Parkinsonian symptom score.
Two subscores for negative symptoms were derived from the SANS. Affective flattening (AF) was the total of six items: unchanging facial expression; decreased spontaneous movements; poverty of expressive gestures; poor eye contact; affective non-responsivity; and lack of vocal inflection. Alogia was derived from the total scores of four items in this section of the SANS: poverty of speech; poverty of content of speech; blocking; and increased latency of response. A CPRS score for positive symptoms was derived as a total for the following items: feeling controlled; disrupted thoughts; ideas of persecution; ideas of grandeur; other delusions; commenting voices; other auditory hallucinations; visual hallucinations; and other hallucinations.
Inter-rater agreement (DAC and MP), each conducting approximately
half the interviews, while the other scored on the basis of replies to questions. Neither rater could see the other's scoring sheet. So as not to disrupt the interview, the scores could be altered at the end, after checking with the glossary of definitions for levels of severity.
Based on these data, the inter-rater reliability for the CPRS items, expressed in terms of Cohen's x, ranged from 0.71 to 1.0, and there was no bias between the raters. The correlations for items referring to reported symptoms were generally slightly higher than those recorded for observed psychopathology, a finding consistent with previous studies of the inter-rater reliability of this scale (Jacobsson ei a!, 1978; Kasa & Hitomi, 1985) .
For the SANS, 17 joint interviews were conducted throughout the study by the two raters (TREB and PFL). Scores for both the AF and alogia subscales were compared. Correlation coefficients were 0.67 (P= 0.004) and 0.57 (P= 0.02) respectively. There was no systematic bias between the two raters: the mean scores for AF were 10.18 (s.d. 4.61) and 9.18 (s.d. 5.02) (paired 1= 1.10, P=0.29).
Similar results were obtained for the ratings of alogia. It should be noted that a higher level of inter-rater agreement could be expected for the CPRS, since patients were asked to describe each symptom in detail, and there are clearly defined anchor points for each item. Comparison of the PSE â€˜¿ depressed' group with the control group at initial assessment revealed a higher mean MADRS score in the former: 15.9 versus 3.44, with the median scores being 17 and 1, with ranges of 3â€"35 and 0â€"12 respectively. This difference was highly significant using a two-tailed 1-test (P<0.OOl) (see Table I ). The Beck depression scores also showed a highly significant difference between the PSE depressed and control groups at initial assessment, the mean scores being 19.5 and 10.2 respectively (P= 0.004). The former score lies within the range for moderate depression, while the latter score falls within the mild depression range (Beck & Beamesderfer, 1974) . The association between the higher mean MADRS score and PSE depressed mood persisted at three-month follow up. The mean MADRS score increased from 1.4 to 15.6 in the five control patients who had developed PSE depressed mood during follow-up, and declined from 13.9 to 4.9 in the ten patients who no longer had PSE depressed mood at follow-up. Within the same two subgroups, the mean Beck depression scores showed similar changes, increasing from 17.8 to 25.5, and declining from 16 to 9.3 respectively. The mean score of 17.8 in the five â€˜¿ non depressed' control patients who developed depressed mood and elevated MADRS scores raises the possibility that a relatively high Beck score might be either an early feature of depression in chronic schizophrenic patients or a trait marker of those patients prone to depression.
There was a significant difference between the two groups in the presence of auditory hallucinations, a variable which combined the CPRS items â€˜¿ commenting voices' and â€˜¿ other auditory hallucinations'. More depressed patients had definite auditory hallucinations, that is, rated asS or more on either of the two items, and when present they were consistently rated as more severe (see Table I ). Also, suicidal thoughts, as rated on the CPRS, were more common in the depressed group. Four patients in the initial depressed group experienced pathological suicidal ideas, that is, At initial assessment, there were no significant differences between those patients with depressed mood and the matched controls on any of the other variables defined above (see Table I ). Indeed, the mean daily dose of antipsychotics was higher in the control group (991 mg) than in the â€˜¿ depressed' group (655 mg). The distribution of oral and depot preparations was similar in the two groups. Sixteen patients in each group were receiving depot antipsychotic drugs. Fluphenazine decanoate was the commonest, being administered to eight patients in the non depressed group and nine in the depressed group. The patients in the two groups were also taking a variety of oral antipsychotic drugs, and nine of the non-depressed group and seven of the depressed group were receiving a combination of oral and depot medication. It was, therefore, not possible to determine the possible contri bution of any particular drug to the depressive picture. Over the follow-up period, only ten patients in the two groups had changes made to their antipsychotic medication: six in the depressed group, the dosage being reduced in four, and four of the control group. Only two patients, both in the depressed group, were receiving antidepressant medication, and this had been discontinued during the three month follow-up in one of them. One patient had recovered from severe depression at follow-up, having restarted lithium carbonate, which he had taken for many years until six months before the initial assessment. There was a trend for a higher mean score in the depressed group compared with the non-depressed group on two variables: the alogia subscore (P= 0.054) and the positive symptom score derived from the CPRS (P= 0.058) (see Table I ). The latter trend mainly reflected the significant difference between the two groups in the presence of auditory hallucinations.
A Pearson correlation coefficient supported a strong association between PSE depressed mood and MADRS scores at both initial and follow-up assessments (r= 0.7, P<0.OOl; r= 0.74, P<0.001). There was no association between either orofacial or trunkal dyskinesia and any other variable, including antipsychotic medication dosage, except for a significant, positive relationship between orofacial dyskinesia and age, which was only found in the original depressed group. The relationship was present both initially (r= 0.57, P= 0.003) and at follow-up (r=0.61, P= 0.001 ).
There were no significant correlations between dosage of antipsychotic medication, akathisia, tardive dyskinesia, Parkinsonism and the positive and negative symptom subscores. There were no significant correlations between MADRS scores and demographic variables such as length of illness and age of onset of the illness.
Discussion
For most patients studied, the presence of depressed mood indicated a depressive syndrome which was rateable on recognised rating scales for affective disorders. This depression was a distressing sub jective experience and persisted beyond three months in three-fifths of those patients originally identified, and emerged in a fifth of the control group over the same period. Over this follow-up period, both the MADRS and Beck scores increased or decreased in parallel with the presence or absence of the PSE depressive symptom, lending support to the idea that the depressive features rated in these patients constituted a valid syndrome of clinical relevance.
Those patients with depressive features were significantly more likely to have serious suicidal thoughts. This finding is consistent with the results of recent studies which suggest that the suicidal risk is higher in schizophrenic patients with depressive symptoms (Roy, 1986; Prasad, 1986) . Between 10Â°1@ and 25Â°lo of schizophrenic patients will commit suicide, and the suicidal behaviour has been considered impulsive and unpredictable (Wanes, 1968; Haugland et a!, 1983) . However, there seems to be accumulating evidence that the presence of
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depressive features can be one clinical indication of an increased likelihood of suicide in a schizophrenic patient.
Perhaps of equal importance with the significant associations found in this study was the failure to demonstrate such associations between mood disturbance and a number of variables previously suggested as contributory causal factors. There was no relationship apparent between depressed mood and dosage of antipsychotic medication. In this respect, our results fail to provide support for the concept of â€˜¿ pharmacogenicdepression'.
Further, no associations were found between depressed mood and Parkinsonism, and the matched groups were equally likely to be receiving anticholinergic medication. These results are incompatible with the notion of drug-related akinesis as a major contributor to depressive features in this patient sample. Rather, the fmding of a significantly higher score for auditory hallucinations and a trend for a higher mean positive symptom score in the group with depressed mood is consistent with the results of studies of acute schizophrenic relapse that suggest that depression may be part of the core psychopathology of schizophrenia (Donlon et a!, 1976; Knights & Hirsch, 1981; Johnson, 1981; Curson et a!, 1985) .
No significant relationship was found between PSE depressed mood, MADRS scores, or the Beck depression score and negative symptoms, even when negative symptoms were separated into features of affective flattening and alogia. Thus, affective flattening emerged as a discrete symptom that was not being confused with depression, nor was it a manifestation of Pakinsonism. The trend for an association between alogia and depression may reflect a degree of psychomotor retardation in the depressed group, as found in primary depressive syndromes. These findings are in accord with those of Prosser et a! (1987) , who found no association between negative symptoms and â€˜¿ cognitive' features of depression.
The finding that schizophrenic patients with depression experienced auditory hallucinations more commonly than their non-depressed fellows does not allow for the easy interpretation that persistent schizophrenic voices will lead to dysphoria. Only one patient in the depressed group specifically attributed his depresion to being due to voices â€˜¿ getting me down'. Descriptions of the content of the hallucinations in the depressed patients suggested that the voices were not predominantly commenting voices, typical of schizophrenia, nor were they purely mood-congruent, as can occur in the affective psychoses. Nevertheless, a tentative hypothesis is that schizophrenic patients who become depressed are likely to develop auditory hallucinations, which may be more characteristic of psychotic depression than of schizophrenia.
Conclusion
Depressed mood was present in approximately one in eight patients within our sample of long-stay, chronic schizophrenic in-patients. It conformed to a typical depressive syndrome, and was distinct from affective flattening; however, some overlap was found between depression and SANS items such as poverty of speech and increased latency of response, symptoms which are recognised as negative symptoms of schizophrenia, but also as characteristic features of depressive illness. The aetiological hypotheses of â€˜¿ pharmacogenic' or â€˜¿ akinetic' depression were not supported. Whether this apparently typical depressive syndrome in chronic patients is an integral part of schizophrenia, or whether it reflects episodes of depression related to their adverse circumstances and multiple handicaps, remains a matter of speculation.
